000 | 02011 a2200637 4500 | ||
---|---|---|---|
005 | 20250517010509.0 | ||
264 | 0 | _c20150324 | |
008 | 201503s 0 0 eng d | ||
022 | _a1873-5835 | ||
024 | 7 |
_a10.1016/j.leukres.2014.11.009 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aItzykson, Raphael | |
245 | 0 | 0 |
_aAzacitidine for the treatment of relapsed and refractory AML in older patients. _h[electronic resource] |
260 |
_bLeukemia research _cFeb 2015 |
||
300 |
_a124-30 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
650 | 0 | 4 |
_aAzacitidine _xadministration & dosage |
650 | 0 | 4 |
_aBlast Crisis _xdrug therapy |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aThépot, Sylvain | |
700 | 1 | _aBerthon, Céline | |
700 | 1 | _aDelaunay, Jacques | |
700 | 1 | _aBouscary, Didier | |
700 | 1 | _aCluzeau, Thomas | |
700 | 1 | _aTurlure, Pascal | |
700 | 1 | _aPrébet, Thomas | |
700 | 1 | _aDartigeas, Caroline | |
700 | 1 | _aMarolleau, Jean-Pierre | |
700 | 1 | _aRecher, Christian | |
700 | 1 | _aPlantier, Isabelle | |
700 | 1 | _aStamatoullas, Aspasia | |
700 | 1 | _aDevidas, Alain | |
700 | 1 | _aTaksin, Anne-Laure | |
700 | 1 | _aGuièze, Romain | |
700 | 1 | _aCaillot, Denis | |
700 | 1 | _aVey, Norbert | |
700 | 1 | _aAdès, Lionel | |
700 | 1 | _aIfrah, Norbert | |
700 | 1 | _aDombret, Hervé | |
700 | 1 | _aFenaux, Pierre | |
700 | 1 | _aGardin, Claude | |
773 | 0 |
_tLeukemia research _gvol. 39 _gno. 2 _gp. 124-30 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.leukres.2014.11.009 _zAvailable from publisher's website |
999 |
_c24472711 _d24472711 |